Fox Chase Cancer Center Physician to Serve on American Joint Committee on Cancer
PHILADELPHIA (Oct. 3, 2002) -- John Andrew Ridge, M.D., Ph.D., of Ivyland, Pa., has been appointed to serve on the American Joint Committee on Cancer (AJCC) as a representative of the American Head and Neck Society. Ridge has been Fox Chase Cancer Center's chief of head and neck surgery since 1991.
The AJCC's goal is to formulate and publish classifications of cancer, including staging and reporting of end results, which will be used by the medical profession for selecting the most effective treatment, determining prognosis and continuing evaluation of cancer control measures. Members act as liaisons between the AJCC and other professional groups with whom they are affiliated.
In his role at Fox Chase, Ridge directs clinical research on head and neck cancer and also has a strong role in basic research. He attended the University of Chicago before receiving his Ph.D. from Stanford University in biochemistry. He received his M.D. from Stanford University Medical School and served a surgical residency at the University of Colorado.
After a clinical research fellowship and a surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center, Ridge received the Resident Research Award of the Association of Academic Surgery. He joined the faculty of the University of California at San Francisco in 1989 before coming to Fox Chase.
Ridge is a member of the American Head and Neck Society, the American Society of Clinical Oncology, the American Association of Cancer Research, and the American Radium Society. He is a fellow of the Society of Surgical Oncology and the American College of Surgeons.
Ridge is also co-chair of the head and neck committee of the Eastern Cooperative Oncology Group and a member of the head and neck steering committee of the Radiation Therapy Oncology Group. He is one of the members of the Head and Neck Intergroup, convened by the National Institutes of Health to direct clinical research on head and neck cancer.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.